Refusal of COVID-19 and influenza vaccinations was higher among White patients at an allergy/immunology clinic with a diverse patient population.

They pared their gains and were last up 2%. The Maryland-based biotech announced the clinical hold last month after a ...

On NVAX's third-quarter earnings call, investors will likely seek updates on management???s ongoing discussions with the FDA ...

The researchers found that the primary composite reactogenicity outcome was noninferior in the simultaneous vs the sequential group. (HealthDay News) — Reactogenicity is comparable for simultaneous ...

Misconceptions about the influenza and COVID-19 vaccines may make some people hesitant to roll up their sleeves. What better way to clear up the confusion than hearing straight from a Mayo Clinic ...

Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...

So far this year, 18 countries have registered a total of 278 HPAI outbreaks in poultry. This is according to the Animal ...

(RTTNews) - Novavax, Inc. (NVAX) Monday said the Food and Drug Administration or FDA has removed the clinical hold on its COVID-19-Influenza Combination (CIC) and stand-alone influenza vaccine ...

Investing.com -- The U.S. Food and Drug Administration (FDA) has lifted its hold on a late-stage trial for Novavax’s ...

and stand-alone influenza vaccine candidates. The vaccine candidates were placed on clinical hold last month after report of a serious adverse event in a single CIC Phase 2 trial participant who ...